KYTX
Kyverna Therapeutics Inc.

692
Mkt Cap
$384.53M
Volume
1.11M
52W High
$9.75
52W Low
$1.78
PE Ratio
-2.36
KYTX Fundamentals
Price
$8.78
Prev Close
$8.36
Open
$8.56
50D MA
$7.15
Beta
1.86
Avg. Volume
636,227.68
EPS (Annual)
-$3.33
P/B
2.53
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Kyverna Therapeutics (NASDAQ:KYTX) Upgraded to Hold at Wall Street Zen
Wall Street Zen raised shares of Kyverna Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives Average Recommendation of "Moderate Buy" from Analysts
Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five ratings firms that are presently covering the firm, MarketBeat reports...
MarketBeat·8d ago
News Placeholder
William Blair Brokers Increase Earnings Estimates for KYTX
Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) - Equities researchers at William Blair increased their FY2025 earnings estimates for Kyverna Therapeutics in a note issued to investors on...
MarketBeat·28d ago
News Placeholder
FY2025 Earnings Forecast for KYTX Issued By Leerink Partnrs
Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) - Analysts at Leerink Partnrs decreased their FY2025 EPS estimates for shares of Kyverna Therapeutics in a report issued on Wednesday, November...
MarketBeat·28d ago
News Placeholder
Kyverna Therapeutics (NASDAQ:KYTX) Issues Quarterly Earnings Results, Beats Estimates By $0.12 EPS
Kyverna Therapeutics (NASDAQ:KYTX - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.85) earnings per share (EPS) for the quarter, beating the consensus...
MarketBeat·1mo ago
News Placeholder
Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives Average Rating of "Moderate Buy" from Analysts
Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the five brokerages that are currently covering the stock, MarketBeat Ratings...
MarketBeat·1mo ago
News Placeholder
Kyverna Therapeutics (KYTX) Expected to Announce Quarterly Earnings on Wednesday
Kyverna Therapeutics (NASDAQ:KYTX) will be releasing its Q3 2025 earnings before the market opens on Wednesday, November 12. (View Earnings Report at...
MarketBeat·1mo ago

Latest KYTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.